December 16, 2021 |
Anheart Therapeutics Raises $61M in Series B for Precision Oncology Pipeline |
![](images/portfolio/anheart.jpg) |
November 16, 2021 |
ACELYRIN, INC. Closes $250 Million Series B Financing and Announces Licensing of Izokibep |
![](images/portfolio/acelyrin.jpg) |
October 26, 2021 |
Vertex signs another Mammoth-sized CRISPR deal with $650M in Biobucks on the Line |
![](images/portfolio/mammoth-biosciences.jpg) |
September 24, 2021 |
Google Provider of At-home Covid-19 tests is Now a $3 Billion Company Traded on Nasdaq |
![](images/portfolio/cue-health.jpg) |
September 20, 2021 |
Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence |
![](images/portfolio/omniome.jpg) |
September 15, 2021 |
Alpine Immune Sciences Announces $91 Million Private Placement |
![](images/portfolio/alpine-immune.jpg) |
September 9, 2021 |
Mammoth Biosciences Raises $195 Million to Build Next-Generation CRISPR Products in Therapeutics and Diagnostics |
![](images/portfolio/mammoth-biosciences.jpg) |
August 27, 2021 |
Lynk Pharmaceuticals Announces the Completion of Series B Financing of $50 Million |
![](images/portfolio/lynk-pharmaceuticals.jpg) |
August 26, 2021 |
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement |
![](images/portfolio/aadi.jpg) |
August 26, 2021 |
BeyondSpring Announces Exclusive Commercialization And Co-Development Agreement With Jiangsu Hengrui Pharmaceuticals For Plinabulin In Greater China |
![](images/portfolio/beyondspring.jpg) |
August 24, 2021 |
Roche Tees up $3B+ for Shape's RNA Editing Platform |
![](images/portfolio/shape-therapeutics.jpg) |
August 18, 2021 |
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test |
![](images/portfolio/grail.jpg) |
August 4, 2021 |
BeyondSpring Announces Positive Topline Results From Its DUBLIN-3 Rregistrational Trial Of Plinabulin in Combination with Docetaxel |
![](images/portfolio/beyondspring.jpg) |
July 22, 2021 |
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company |
![](images/portfolio/sema4.jpg) |
July 20, 2021 |
Pacific Biosciences Signs Definitive Agreement to Acquire Omniome |
![](images/portfolio/omniome.jpg) |
July 17, 2021 |
Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy |
![](images/portfolio/shape-therapeutics.jpg) |
July 15, 2021 |
AnHeart Therapeutics Announces License Agreement with NewG Lab for Taletrectinib Rights in Korea |
![](images/portfolio/anheart.jpg) |
July 14, 2021 |
Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy |
![](images/portfolio/cellares.jpg) |
June 23, 2021 |
Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases |
![](images/portfolio/adela.jpg) |
June 2, 2021 |
SCYNEXIS Announces FDA Approval of BREXAFEMME® (ibrexafungerp tablets) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections |
![](images/portfolio/scynexis.jpg) |
May 31, 2021 |
Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China |
![](images/portfolio/anheart.jpg) |
May 27, 2021 |
GenapSys Rakes in $70M for Tabletop Genomic Sequencing Platform |
![](images/portfolio/genapsys.jpg) |
May 17, 2021 |
Hummingbird Bioscience Raises US$125 Million in Series C Financing |
![](images/portfolio/hummingbird-bioscience.jpg) |
May 17, 2021 |
Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive Merger Agreement |
![](images/portfolio/aadi.jpg) |
May 13, 2021 |
Cue Health Announces Completion of $235 Million Private Financing to Accelerate Growth |
![](images/portfolio/cue-health.jpg) |
May 5, 2021 |
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing |
![](images/portfolio/cellares.jpg) |
March 24, 2021 |
Bioheng Biotech Raised $80 million in Series B Financing to Advance Allogeneic Immuno-Cell Therapies |
![](images/portfolio/bioheng.jpg) |
March 23, 2021 |
EpimAb Biotherapeutics Raises $120M in Series C Financing to Advance Bispecific Programs and Broaden Clinical Pipeline |
![](images/portfolio/epimab.jpg) |
March 5, 2021 |
FDA Authorizes Cue Health’s COVID-19 Test for At-Home and Over The Counter Use |
![](images/portfolio/cue-health.jpg) |
February 10, 2021 |
Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth |
![](images/portfolio/sema4.jpg) |
February 10, 2021 |
Terns Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares |
![](images/portfolio/terns.jpg) |
February 5, 2021 |
Equillium Announces Closing of $30 Million Registered Direct Offering |
![](images/portfolio/equillium.jpg) |
January 6, 2021 |
LevitasBio Raises $18M in Series B Financing, Forms JV With Thalys Medical in China |
![](images/portfolio/levitas.jpg) |
January 5, 2021 |
Lilly-backed Terns raises $87M for multi-front assault on NASH |
![](images/portfolio/terns.jpg) |